Cargando…
Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921491/ https://www.ncbi.nlm.nih.gov/pubmed/20552178 http://dx.doi.org/10.1007/s00228-010-0854-x |
_version_ | 1782185393638080512 |
---|---|
author | Cubała, Wiesław Jerzy Wiglusz, Mariusz Burkiewicz, Anna Gałuszko-Węgielnik, Maria |
author_facet | Cubała, Wiesław Jerzy Wiglusz, Mariusz Burkiewicz, Anna Gałuszko-Węgielnik, Maria |
author_sort | Cubała, Wiesław Jerzy |
collection | PubMed |
description | |
format | Text |
id | pubmed-2921491 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-29214912010-08-20 Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor Cubała, Wiesław Jerzy Wiglusz, Mariusz Burkiewicz, Anna Gałuszko-Węgielnik, Maria Eur J Clin Pharmacol Letter to the Editors Springer-Verlag 2010-06-16 2010 /pmc/articles/PMC2921491/ /pubmed/20552178 http://dx.doi.org/10.1007/s00228-010-0854-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Letter to the Editors Cubała, Wiesław Jerzy Wiglusz, Mariusz Burkiewicz, Anna Gałuszko-Węgielnik, Maria Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor |
title | Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor |
title_full | Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor |
title_fullStr | Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor |
title_full_unstemmed | Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor |
title_short | Zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving CYP3A: sex as a differentiating factor |
title_sort | zolpidem pharmacokinetics and pharmacodynamics in metabolic interactions involving cyp3a: sex as a differentiating factor |
topic | Letter to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2921491/ https://www.ncbi.nlm.nih.gov/pubmed/20552178 http://dx.doi.org/10.1007/s00228-010-0854-x |
work_keys_str_mv | AT cubaławiesławjerzy zolpidempharmacokineticsandpharmacodynamicsinmetabolicinteractionsinvolvingcyp3asexasadifferentiatingfactor AT wigluszmariusz zolpidempharmacokineticsandpharmacodynamicsinmetabolicinteractionsinvolvingcyp3asexasadifferentiatingfactor AT burkiewiczanna zolpidempharmacokineticsandpharmacodynamicsinmetabolicinteractionsinvolvingcyp3asexasadifferentiatingfactor AT gałuszkowegielnikmaria zolpidempharmacokineticsandpharmacodynamicsinmetabolicinteractionsinvolvingcyp3asexasadifferentiatingfactor |